Allianz Se (AZSEY) 16.0900 $AZSEY Stock Futures

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allianz Se (AZSEY) 16.0900 $AZSEY

Stock Futures Moderately Lower; Monster, Nvidia, Arista Climbing
at Investor's Business Daily - Fri Aug 07, 8:04AM CDT
Stock futures sifted deeper into losses Friday after a no-surprise report on July payroll growth. Dow futures were 26.7 points below fair market value compared with a five-point loss an hour earlier. Nasdaq 100 futures were 11 points lower, S&P 500...
KO: 38.13 (-0.29), ANET: 64.46 (-5.42), NOAH: 20.74 (+0.01), MNST: 132.77 (+0.53), HSY: 91.21 (+0.50), ED: 62.39 (+0.82), NDLS: 12.20 (+0.07), STMP: 80.49 (+0.64), NVDA: 22.65 (+0.07)

A.M. Best Affirms Ratings of Allianz SE and Most of Its Subsidiaries
Business Wire - Thu Aug 06, 9:25AM CDT
A.M. Best has affirmed the financial strength ratings (FSR) of A+ (Superior) and the issuer credit ratings (ICR) of "aa-" of Allianz SE (Allianz) (Germany) and most of its A.M. Best rated subsidiaries. In addition, A.M. Best has upgraded the FSR to A+ (Superior) from A (Excellent) and the ICR to "aa-" from "a" of Fireman's Fund Insurance Company (Fireman's Fund) (Novato, CA) and its reinsured affiliates, collectively referred to as FFIC. Furthermore, A.M. Best has upgraded the FSR to A+ (Superior) from A (Excellent) and the ICR to "aa-" from "a+" of Allianz Life Insurance Company of North America (Minneapolis, MN) and its subsidiary, Allianz Life Insurance Company of New York (New York, NY) (collectively known as Allianz Life). Concurrently, A.M. Best has affirmed the issue ratings of Allianz's debt securities. The outlook for all ratings is stable. (See below for a detailed listing of company ratings).

Travelers Is Looking for Acquisitions; The Hartford Could Be a Target
at The Street - Tue Jul 21, 2:20PM CDT
Hartford Group has been caught in a flurry of takeover speculation, with its shares spiking on the heels of Chubb's acquisition of ACE. Some see Travelers as a potential suitor.
ACE: 100.86 (+0.12), C: 51.10 (+0.03), CB: 120.90 (+0.24), AIG: 58.33 (+0.11), BRK.A: 198,329.00 (+690.00), ALL: 58.14 (+0.47), HIG: 45.95 (+0.14), TRV: 99.49 (+0.40)

3 Reasons Value Stock Investors Will Love Allianz (AZSEY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 25, 7:33AM CDT
There are numerous reasons that make Allianz a great choice for value investors

Greece Fire: Eurozone Stocks Rally On Alleged Progress
at Investor's Business Daily - Mon Jun 22, 4:36PM CDT
International markets gave a sense Monday as to just how much pressure Greece's uncertain future within the eurozone has placed on global stock action. The optimism started in Europe after Prime Minister Alexis Tsipras and the Greek government...
BCS: 16.03 (-0.01), TOT: 45.12 (-0.01), HSBC: 39.12 (+0.06), DB: 29.22 (-0.02), RBS: 10.19 (+0.02), LYG: 4.74 (-0.02), SNY: 50.23 (+0.46), ORAN: 15.60 (-0.48)

Bill Gross wins over old Pimco client
Seeking Alpha - at Seeking Alpha - Fri Jun 05, 1:54PM CDT

JNS: 14.72 (+0.17)

Morningstar: Pimco culture improving post-Gross
Seeking Alpha - at Seeking Alpha - Thu Jun 04, 1:41PM CDT


Allianz Less Robust On Growth, But Loaded On Quality
Stephen Simpson, CFA - at Seeking Alpha - Thu Jun 04, 10:03AM CDT


HSBC to Boost Profitability: Is Massive Job Cut on Cards? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 02, 1:55PM CDT
In a major strategic overhaul, HSBC is planning to unveil thousands of additional job cuts on the upcoming Investor Day conference on Jun 9.
BLK: 303.31 (+2.00), HSBC: 39.12 (+0.06), UBS: 20.76 (+0.12)

Exits from Pimco's Total Return slow
Seeking Alpha - at Seeking Alpha - Tue Jun 02, 7:35AM CDT

AGG: 109.06 (+0.13)

BofA & U.S. Bancorp Win Dismissal of 3 RMBS Lawsuits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 19, 2:20PM CDT
In a major relief to U.S. Bancorp and BofA, 3 cases related to their alleged failure in performing duties as trustees for RMBS were dismissed.
USB: 41.06 (-0.04), BLK: 303.31 (+2.00), BAC: 16.04 (unch)

Elizabeth Warren Is Worried About Annuities: Should You Be, Too?
Selena Maranjian, The Motley Fool - Motley Fool - Mon May 18, 9:03AM CDT
Source: www.warren.senate.gov If you're a financial-services company, can there be a scarier sound than the footsteps of Elizabeth Warren approaching you? Senator Warren is famous on Wall Street and beyond for taking on banks and other financial...
PRU: 78.99 (+0.04), AIG: 58.33 (+0.11), LNC: 49.93 (+0.19)

Take Cover In These Interesting Value Plays
Joe Leider - at Seeking Alpha - Sat May 16, 10:32AM CDT
I've said stocks are fairly valued , and my expectation of long-term yields and current stock valuations still justify that analysis. But like in George Orwell's Animal Farm , some stocks are more fairly valued than others. I've looked into Warren...
TNH: 110.34 (-0.24), ARII: 40.17 (-0.10), ADM: 42.82 (-0.24), UFS: 39.03 (-0.29), TX: 14.40 (-0.10), CAT: 72.63 (+0.21), LDOS: 42.61 (+0.31)

Pimco equities push foundering
Seeking Alpha - at Seeking Alpha - Thu May 14, 1:37PM CDT


Allianz's (AZSEY) CEO Michael Diekmann on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue May 12, 1:00PM CDT


Allianz Global Investors Names Next CEO US
Business Wire - Tue May 05, 1:24PM CDT
Allianz Global Investors (AllianzGI), an asset management company of Allianz SE, announced today that Brian Gaffney will retire from the firm as CEO US at the end of the year. Douglas Eu, currently CEO Asia Pacific, will succeed Brian as CEO US in 2016.

Wall Street Breakfast: Eurozone Growth Forecast Gets Big Boost
Wall Street Breakfast - at Seeking Alpha - Tue May 05, 5:30AM CDT

PXD: 118.36 (-2.90), SPY: 196.74 (+0.89), QQQ: 105.57 (+0.58), PNRA: 182.62 (+2.76), CMG: 729.06 (+5.87), HSBC: 39.12 (+0.06), UBS: 20.76 (+0.12), KKR: 18.50 (+0.13), CSCO: 26.02 (-0.24)

Pimco's Total Return loses world's largest bond fund title
Seeking Alpha - at Seeking Alpha - Mon May 04, 3:13PM CDT


Ben Bernanke Gives Pimco Star Power After Gross Exit
at Investor's Business Daily - Wed Apr 29, 11:55AM CDT
Former Federal Reserve Chairman Ben Bernanke has been hired as a senior adviser to bond giant Pacific Investment Management Co. (Pimco), giving a big-name boost to the firm after the abrupt departure of co-founder Bill Gross last year. Bernanke, who...
JNS: 14.72 (+0.17)

Bernanke joins Pimco as senior advisor
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 9:38AM CDT


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading